Per Cantor

44 papers receiving 1.7k citations

Per Cantor's Hit Papers

The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer 2008 · 483 citations
4830+6+12Years since publication100200300400

Peers

Per Cantor
Comparison fields: 5 of 80
  • Endocrinology, Diabetes and Metabolism 454
  • Cellular and Molecular Neuroscience 505
  • Endocrine and Autonomic Systems 122
  • Orthopedics and Sports Medicine 147
  • Oncology 397
Replace Jan Axelson with:
Jan Axelson Sweden
Birgitta Ryberg Sweden
Fischer Ja Switzerland
Jeremy L. Beacham United Kingdom
Morten Wøjdemann Denmark
J.-J. Girard Switzerland
Antonio Kokot Croatia
Thomas P. Conlon United States
Kensei Yahata Japan
Miina K. Öhman United States
Per Cantor relative to Jan Axelson Sweden Jan Axelson's profile →
Citations per field
00.5×2×4×5.5×
Jan Axelson · 1×
Citations per year

Countries citing papers authored by Per Cantor

Since Specialization
Citations

This map shows the geographic impact of Per Cantor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Cantor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Cantor more than expected).

Fields of papers citing papers by Per Cantor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Cantor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Cantor. The network helps show where Per Cantor may publish in the future.

Co-authors

The 25 scholars most cited alongside Per Cantor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per Cantor Line = papers co-authored together Per Cantor links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer
Hit paper breakdown →
2008483
2 2005174
3 1987152
4 198998
5 198693
6 199280
7 199572
8 198747
9 199244
10 198638
11 198937
12 198634
13 198631
14 198829
15 199128
16 198727
17 198824
18 198923
19 198520
20 198718

About Per Cantor

Per Cantor is a scholar working on Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism, Surgery, Oncology and Epidemiology, having authored 45 papers that have together received 1.7k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (29 papers), Neuroendocrine Tumor Research Advances (10 papers), Diabetes Treatment and Management (10 papers), Peptidase Inhibition and Analysis (7 papers), Pancreatitis Pathology and Treatment (5 papers), Pancreatic function and diabetes (5 papers), Gastrointestinal motility and disorders (4 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (454 citations), Cellular and Molecular Neuroscience (505 citations), Endocrine and Autonomic Systems (122 citations), Orthopedics and Sports Medicine (147 citations) and Oncology (397 citations). Per Cantor has collaborated with scholars based in Denmark, Sweden and Germany. Frequent co-authors include Bo‐Eric Persson, Jens-Kristian Jensen, Fritz H. Schröder, Laurence H. Klotz, Neal D. Shore, LAURENT BOCCON-GIBOD, Tine Kold Olesen, Jens Frederik Rehfeld, W. Creutzfeldt and Ole Olsen. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Digestion, Pancreas, Gastroenterology and Acta Oncologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact